Canaccord Genuity Maintains Buy on Natures Sunshine Products, Lowers Price Target to $36
Personal Care Stocks Q1 In Review: Nature's Sunshine (NASDAQ:NATR) Vs Peers
3 Reasons to Sell NATR and 1 Stock to Buy Instead
How The Story Around Nature’s Sunshine (NATR) Is Shifting After Q4 And New Analyst Targets
Nature's Sunshine: A Herbal Engine With Digital Roots Starting To Show
How The Nature’s Sunshine (NATR) Narrative Is Shifting With Q4 Beats And Digital Growth
NATR Q1 Deep Dive: Digital Channel Expansion and Margin Gains Shape Outlook
Nature's Sunshine Products, Inc. Just Beat EPS By 41%: Here's What Analysts Think Will Happen Next
Nature's Sunshine Products Q1 Earnings Call Highlights
Nature's Sunshine Products, Inc. Q1 2026 Earnings Call Summary
Nature’s Sunshine (NASDAQ:NATR) Surges 13% After Q1 Earnings Beat
NATR Q1 2026 Earnings Transcript
Nature's Sunshine’s (NASDAQ:NATR) Q1 CY2026: Beats On Revenue
Nature's Sunshine Reports Strong First Quarter 2026 Results
Nature's Sunshine Products, Inc. (NATR) Q1 2026 Earnings Call Transcript
Nature's Sunshine Products, Inc. 2026 Q1 - Results - Earnings Call Presentation
Natures Sunshine Products Affirms FY2026 Sales Guidance of $500.000M-$515.000M vs $507.267M Est
Natures Sunshine Products Q1 Adj. EPS $0.30 Beats $0.23 Estimate, Sales $122.892M Beat $122.728M Estimate
Nature’s Sunshine Appoints John Hnanicek as Chief Technology Officer
How The Nature’s Sunshine Products (NATR) Story Is Shifting Around Q4 Results And US$33 Target
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.